Sirohia Sons Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Sirohia & Sons Ltd is ₹ 6.52 as of 19 Aug 15:30 . The P/E Ratio of Sirohia & Sons Ltd changed from 116.4 on March 2024 to 242.3 on March 2026 . This represents a CAGR of 27.68% over 3 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Sirohia & Sons Ltd changed from ₹ 8.88 crore on March 2022 to ₹ 7.46 crore on March 2026 . This represents a CAGR of -3.42% over 5 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Sirohia & Sons Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 1.46 crore. This represent the decline of -100% The ebitda of Sirohia & Sons Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ -49.86 crore as compare to the Dec '25 ebitda of ₹ 1.43 crore. This represent the decline of -3586% The net profit of Sirohia & Sons Ltd changed from ₹ -0.03 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ -49.86 crore over 8 quarters. This represents a CAGR of 1110.98% The Dividend Payout of Sirohia & Sons Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Sirohia & Sons Ltd

Sirohia & Sons Limited was originally incorporated in Kolkata as 'Sirohia & Sons Private Limited' on 28th May, 1990 issued by the Registrar of Companies, West Bengal.
The Company was converted into a Public Limited Company and name was changed to Sirohia & Sons Limited dated 18th June, 2013 with due approval from the Registrar of Companies, West Bengal.
The Company's core business is distribution and marketing of agrochemicals along with some industrial chemicals. Sirohia & Sons Ltd was founded in 1998 as a 'distribution company' only.
Over the years, product lines were expanded by bringing in a host of other chemicals under its own brand name.
Currently, they have become the leading distributor and marketer of agro chemicals in tea plantation industry and a prominent seller of organic and inorganic products in other crops also.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Sirohia & Sons Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Sirohia & Sons Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Sirohia & Sons Ltd is 6 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Sirohia & Sons Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Sirohia & Sons Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sirohia & Sons Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the Sirohia & Sons Ltd stock price is INR ₹6.52. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Sirohia & Sons Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Sirohia & Sons Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.